Publiseringer

Bok eller del av bok/rapport

• Overdoseboka. En helhetlig gjennomgang.

  2025:

  Linn Gjersing,

  Hilde Marie Erøy Edvardsen,

  Thomas Clausen,

  Anne Kristine Bergem,

  Kristin Buvik,

  Desiree Eide,

  Espen Freng,

  Kristin Hanoa,

  Stine Sundsbø Hollerud,

  Marthe Sønsthagen Johansen

Tidsskriftspublikasjon

• Mortality during and following treatment with extended-release naltrexone based on data from two clinical trials

  2025:

  Linn Gjersing,

  Lars Håkon Reiestad Tanum,

  Bente Margrethe Weimand,

  Kristin Klemmetsby Solli
• Health care service utilization and drug overdose death: A national nested case–control registry study

  2024:

  Linn Gjersing,

  Ellen Johanna Amundsen
• Heightened mortality risk after a non‐fatal opioid overdose: Risk factors for mortality in the week following emergency treatment

  2024:

  Desiree Eide,

  Linn Gjersing,

  Aksel Wüsthoff Danielsen,

  Arne Kristian Skulberg,

  Ola Dale,

  Anne-Cathrine Braarud,

  Fridtjof Heyerdahl,

  Ida Karin Tylleskär
• Patterns of filled prescriptions and the association with risk of drug-induced death. A population-based nested case-control register study

  2024:

  Ellen Johanna Amundsen,

  Ingvild Odsbu,

  Svetlana Ondrasova Skurtveit,

  Linn Gjersing
• Increases in drug overdose deaths in Norway and the United States during the COVID-19 pandemic

  2022:

  Joseph Friedman,

  Linn Gjersing
• Individuals Dying of Overdoses Related to Pharmaceutical Opioids Differ from Individuals Dying of Overdoses Related to Other Substances: A Population-Based Register Study

  2022:

  Svetlana Ondrasova Skurtveit,

  Ingvild Odsbu,

  Linn Gjersing,

  Marte Handal,

  Torgeir Gilje Lid,

  Thomas Clausen,

  Aleksi Hamina
• A COVID-19 Survey among People Who Use Drugs in Norway

  2022:

  Gabrielle Welle-Strand,

  Linn Gjersing,

  Ida Keihl Olsen,

  Thomas Clausen
• Increasing trend in accidental pharmaceutical opioid overdose deaths and diverging overdose death correlates following the opioid prescription policy liberalization in Norway 2010–2018

  2022:

  Linn Gjersing,

  Ellen Johanna Amundsen
• Attitudes towards cannabis use legalization and openness to legal use among young partygoers in Norway

  2022:

  Jasmina Burdzovic Andreas,

  Anne Line Bretteville-Jensen,

  Linn Gjersing
• Characteristics and risk of incarceration among “hard-to-reach” people who use drugs: A five-year prospective cohort study combining self-reports and registry data

  2021:

  Linn Gjersing,

  Anne Line Bretteville-Jensen
• Injecting Alone is More Common among Men, Frequent Injectors and Polysubstance Users in a Sample of People Who Inject Drugs

  2021:

  Linn Gjersing,

  Marte Kristin Helle
• “Hooked on the needle”: Exploring the paradoxical attractions towards injecting drug use

  2021:

  Kristin Hanoa,

  Ola Røed Bilgrei,

  Kristin Buvik,

  Linn Gjersing
• COVID-19 survey among people who use drugs in three cities in Norway

  2020:

  Gabrielle Welle-Strand,

  Svetlana Skurtveit,

  Thomas Clausen,

  Christine Sundal,

  Linn Gjersing
• Prehospital naloxone administration – what influences choice of dose and route of administration?

  2020:

  Ida Tylleskär,

  Linn Gjersing,

  Lars Petter Bache-Wiig Bjørnsen,

  Anne-Cathrine Braarud,

  Fridtjof Heyerdahl,

  Ola Dale,

  Arne Kristian Skulberg
• How may alternative drug policy settings influence criminal charges? A longitudinal study of cannabis patients and a general population sample

  2020:

  Anne Line Bretteville-Jensen,

  Jenny Williams,

  Linn Gjersing
• Identification and Assessment of Drug-User Groups Among Nightlife Attendees: Self-Reports, Breathalyzer-Tests and Oral Fluid Drug Tests

  2019:

  Anne Line Bretteville-Jensen,

  Jasmina Burdzovic,

  Linn Gjersing,

  Elisabeth Leere Øiestad,

  Hallvard Gjerde
• Correspondence between Oral Fluid Drug Test Results and Self-Reported Illicit Drug Use among Music Festival Attendees

  2019:

  Hallvard Gjerde,

  Linn Gjersing,

  Håvard Furuhaugen,

  Anne Line Bretteville-Jensen
• Illegal substance use among 1,309 music festival attendees: An investigation using oral fluid sample drug tests, breathalysers and questionnaires

  2019:

  Linn Gjersing,

  Anne Line Bretteville-Jensen,

  Håvard Furuhaugen,

  Hallvard Gjerde
• Naloxone distribution and possession following a large-scale naloxone programme

  2019:

  Desiree Madah-Amiri,

  Linn Renathe Gjersing,

  Thomas Clausen
• Drug use by music festival attendees: A novel triangulation approach using self-reported data and test results of oral fluid and pooled urine samples

  2019:

  Hallvard Gjerde,

  Linn Gjersing,

  Jose Antonio Baz-Lomba,

  Lubertus Bijlsma,

  Noelia Salgueiro-González,

  Håvard Furuhaugen,

  Anne Line Bretteville-Jensen,

  Félix Hernández,

  Sara Castiglioni,

  Ellen Johanna Amundsen
• Patterns of substance use and mortality risk in a cohort of 'hard-to-reach' polysubstance users

  2018:

  Linn Renathe Gjersing,

  Anne Line Bretteville-Jensen
• Emergency service use is common in the year before death among drug users who die from an overdose

  2017:

  Linn Renathe Gjersing,

  Kristine Vinge-Holmquist,

  Svetlana Skurtveit,

  Jørgen Gustav Bramness,

  Thomas Clausen
• Bidrar opplæring av ansatte i språk og språkobservasjoner til økt brukertilfredshet hos beboerne i et lavterskel hybelhus?

  2016:

  Stian Biong,

  Linn Renathe Gjersing
• Misuse of prescription drugs and overdose deaths

  2016:

  Christian Tjagvad,

  Svetlana Skurtveit,

  Jørgen Gustav Bramness,

  Linn Renathe Gjersing,

  Michael Gossop,

  Thomas Clausen
• Are overdoses treated by ambulance services an opportunity for additional interventions? A prospective cohort study

  2015:

  Linn Renathe Gjersing,

  Anne Line Bretteville-Jensen
• Illicit use of opioid substitution drugs: Prevalence, user characteristics, and the association with non-fatal overdoses

  2015:

  Anne Line Bretteville-Jensen,

  Mats Lillehagen,

  Linn Renathe Gjersing,

  Jasmina Burdzovic Andreas
• Open drug scenes: responses of five European cities

  2014:

  Helge Waal,

  Thomas Clausen,

  Linn Renathe Gjersing,

  Michael Gossop
• Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users

  2014:

  Linn Renathe Gjersing,

  Anne Line Bretteville-Jensen
• Is opioid substitution treatment beneficial if injecting behaviour continues?

  2013:

  Linn Renathe Gjersing,

  Anne Line Bretteville-Jensen
• Diversity in causes and characteristics of drug-induced deaths in an urban setting

  2013:

  Linn Gjersing,

  Kristine V. Jonassen,

  Stian Biong,

  Edle Ravndal,

  Helge Waal,

  Jørgen G. Bramness,

  Thomas Clausen

• Holdninger og behandlinger

  2011:

  Linn Renathe Gjersing,

  Thomas Clausen
• Variations in treatment organisation, practices and outcomes within the Norwegian Opioid Maintenance Treatment Programme

  2011:

  Linn Renathe Gjersing,

  Helge Waal,

  Jo Røislien,

  Michael Gossop,

  Thomas Clausen
• Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment

  2010:

  Linn Renathe Gjersing,

  Helge Waal,

  John RM Caplehorn,

  Michael Gossop,

  Thomas Clausen
• Sjokkbølge- og trykkbølgebehandling ved kroniske muskel- og skjelettsmerter

  2010:

  Kjersti Storheim,

  Linn Renathe Gjersing,

  Kristin Bølstad,

  May Arna Risberg
• Cross-cultural adaptation of research instruments: language, setting, time and statistical considerations

  2010:

  Linn Renathe Gjersing,

  John RM Caplehorn,

  Thomas Clausen

• BENZODIAZEPINE USE AMONG PATIENTS IN OPIOID MAINTENANCE TREATMENT (OMT) CENTRES WITH DIFFERENT TREATMENT APPROACHES

  2009:

  Linn Renathe Gjersing,

  Helge Waal,

  Thomas Clausen
• Attitudes and beliefs towards methadone maintenance treatment among Australian prison health staff

  2007:

  Linn Renathe Gjersing,

  T Butler,

  JRM Caplehorn,

  JM Belcher,

  R Matthews

Rapport/avhandling

• Narkotikautløste dødsfall 2023

  2024:

  Linn Gjersing
• Rusmiddelbruk blant personer rekruttert fra lavterskeltiltak og gateplan -Et øyeblikksbilde og en sammenligning med rusmiddelbruk blant deltakere rekruttert i 2013 og 2017

  2023:

  Linn Gjersing

• Risikofylte inntaksmetoder av rusmidler. Resultater fra en kvalitativ studie av 80 personer som bruker stoff med sprøyte

  2020:

  Kristin Hanoa,

  Ola Røed Bilgrei,

  Kristin Buvik,

  Linn Gjersing

• RUSS-19: En studie blant deltakere på tre store russesamlinger våren 2019

  2020:

  Anne Line Bretteville-Jensen,

  Johanna Katarina Blomster Lyshol,

  Jasmina Burdzovic Andreas,

  Linn Gjersing,

  Hallvard Gjerde,

  Håvard Furuhaugen
• RUSS-19: En studie blant deltakere på tre store russesamlinger våren 2019

  2020:

  Anne Line Bretteville-Jensen,

  Johanna Johanna Katarina Bloms Lyshol,

  Jasmina Burdzovic Andreas,

  Linn Gjersing,

  Hallvard Gjerde,

  Håvard Furuhaugen
• Public Health Report – short version Health Status in Norway 2018

  2018:

  Tone Bruun,

  Eva Marie-Louise Denison,

  Linn Gjersing,

  Trine Husøy,

  Ann Kristin Skrindo Knudsen,

  Bjørn Heine Strand,

  Else Karin Grøholt,

  Linn Bøhler,

  Hanna Hånes
• Narkotika i Norge

  2018:

  Linn Renathe Gjersing,

  Ellen Johanna Amundsen
• Folkehelserapporten - kortversjon. Helsetilstanden i Norge 2018. 2. utgave

  2018:

  Tone Bruun,

  Eva Marie-Louise Denison,

  Linn Gjersing,

  Trine Husøy,

  Ann Kristin Skrindo Knudsen,

  Bjørn Heine Strand

• Narkotika på gateplan i 7 norske byer

  2014:

  Linn Renathe Gjersing,

  Thomas Anton Sandøy

• Staff attitudes towards opioid maintenance treatment (OMT) and the associations with treatment

  2011:

  Linn Renathe Gjersing,

  Thomas Clausen,

  Helge Waal

• Open Drug Scenes and Overdose Mortality - What to Do? Lessons from five European cities

  2011:

  Helge Waal,

  Linn Renathe Gjersing,

  Thomas Clausen

• Dødelige overdoser i Oslo 2006 til 2008 : En helhetlig gjennomgang

  2011:

  Linn Renathe Gjersing,

  Stian Nissen Biong,

  Edle Ravndal,

  Helge Waal,

  Jørgen Gustav Bramness,

  Thomas Clausen

• Evaluering av Klinikk Motivasjon (SERAF rapport 3/2009)

  2009:

  Linn Renathe Gjersing,

  Helge Waal,

  Thomas Clausen

Konferansebidrag og faglig presentasjon

• Fatal overdoses in a cohort of chronic pain patients

  2022:

  Aleksi Hamina,

  Ingvild Odsbu,

  Vidar Hjellvik,

  Linn Gjersing,

  Torgeir Gilje Lid,

  Thomas Clausen,

  Svetlana Ondrasova Skurtveit

• Pet ownership among people with substance use disorder: implications for health and use of treatment services

  2019:

  Andi Kerr-Little,

  Ruth C. Newberry,

  Anne Line Bretteville-Jensen,

  Linn Gjersing,

  Ingeborg Bolstad,

  Jenny Skumsnes Moe,

  Stian Biong,

  Jørgen Gustav Bramness

• Fatal overdoses in Oslo 2006-2008

  2011:

  Linn Renathe Gjersing

• Measuring staff attitudes: Why does it matter?

  2011:

  Linn Renathe Gjersing

• Holdninger til og kunnskap om LAR i Norge

  2011:

  Linn Renathe Gjersing

• Lessons learned from a study of European cities

  2011:

  Helge Waal,

  Linn Renathe Gjersing

• Factors associated with fatal overdoses 2006-2008

  2011:

  Linn Renathe Gjersing

• The Oslo situation "Plata" What is suggested and what has been done?

  2011:

  Linn Renathe Gjersing,

  Helge Waal

• A descriptive registry study of those who died from drug-induced deaths between 2006-2008 in Oslo

  2011:

  Linn Renathe Gjersing,

  Kristine Vinge Jonassen,

  Svetlana Skurtveit,

  Jørgen Gustav Bramness,

  Thomas Clausen

• Klinikk Motivasjon –en evaluering

  2010:

  Linn Renathe Gjersing,

  Marius Løken

• Klinikk Motivasjon

  2009:

  Linn Renathe Gjersing

• Ulikheter i LAR

  2009:

  Linn Renathe Gjersing

• Klinikk Motivasjon –en evaluering

  2009:

  Linn Renathe Gjersing

• Holdninger til og kunnskap om LAR

  2009:

  Linn Renathe Gjersing

• Klinikk Motivasjon

  2009:

  Linn Renathe Gjersing

• Klinikk Motivasjon- en evaluering

  2009:

  Linn Renathe Gjersing

• Kort presentasjon av Holdningstudie og evaluering av Klinikk Motivasjon

  2009:

  Linn Renathe Gjersing

• ”Klinikk Motivasjon- en evaluering” og ” ”Har holdninger til LAR noen betydning i behandling og rehabilitering?”

  2009:

  Linn Renathe Gjersing

• Klinikk Motivasjon –en evaluering

  2009:

  Linn Renathe Gjersing

Diverse

• Introduction to the special section on polysubstance use: Emerging trends, psychosocial drivers, and treatment challenges

  2025:

  Amanda Bunting,

  Linn Gjersing,

  Robert Raffa

• Overdosedødsfall: Tiltakene er ikke lenger tilstrekkelige

  2024:

  Linn Gjersing

• Tiltakene vi har mot overdosedødsfall, er ikke lenger tilstrekkelige

  2024:

  Linn Gjersing

• Finnes det en høy andel «skjulte», ressurssterke og ikke-injiserende brukere som handler i Brugata? Vi tror ikke det.

  2016:

  Ayna Beate Johansen,

  Linn Renathe Gjersing

• Som rusforskere er vi bekymret over tabloid journalistikk om rus

  2016:

  Ayna Beate Johansen,

  Linn Renathe Gjersing

• Overdosedødsfall i Norge

  2013:

  Anne Line Bretteville-Jensen,

  Linn Renathe Gjersing

• Lærer ruspolitikk av suksessbyer

  2011:

  Elin Fugelsnes,

  Linn Renathe Gjersing

• "Kan bli kvitt Plata"

  2011:

  Thomas Olsen,

  Linn Renathe Gjersing

• Forskjellene vil øke

  2009:

  Linn Renathe Gjersing

• Klinikk Motivasjon

  2009:

  Linn Renathe Gjersing

• Selvtilfreds kursledelse - sett fra den andre siden

  2008:

  Linda Elise Wusthoff,

  Ingrid Amalia Havnes,

  Linn Renathe Gjersing,

  Astrid Brandsberg Willersrud